Development and validation of a novel slow-release herbal extract-based topical formulation for diabetic foot ulcer management.

Project Abstract

A novel slow-release topical formulation incorporating standardized herbal extracts with proven antimicrobial, anti-inflammatory, and wound-healing properties was developed and validated for the management of diabetic foot ulcers (DFUs). The study employed a systematic approach to formulation development, in vitro characterization, ex vivo permeation, and in vivo validation to establish a robust, patient-friendly therapy with prolonged shelf-life and improved adherence. Plant-derived constituents including extracts rich in flavonoids, terpenoids, and phenolic compounds were selected based on their reported synergistic effects on angiogenesis, collagen synthesis, keratinocyte proliferation, and microbial control in DFUs. A multilayer design was optimized to achieve controlled release over 12–24 hours, minimizing peak-trough fluctuations and reducing application frequency. The formulation matrix incorporated biocompatible polymeric carriers and permeation enhancers to facilitate targeted delivery to wound beds while maintaining a moist healing environment. Physicochemical characterization demonstrated uniform viscosity, appropriate rheological behavior for topical application, and stability under accelerated and real-time conditions. In vitro release profiles indicated sustained drug liberation with near-zero-order kinetics across reservoir and hydrogel configurations, and correlation with Higuchi and Korsmeyer-Peppas models suggested diffusion-controlled mechanisms modulated by the gel matrix and plant actives. Antimicrobial assays against common DFU pathogens, including Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecalis, showed significant inhibition zones and reduced biofilm formation compared with conventional formulations. Cytotoxicity testing on human dermal fibroblasts and keratinocytes indicated high biocompatibility at therapeutic concentrations, with a favorable safety margin for chronic use. Ex vivo permeation studies using porcine skin confirmed controlled transdermal flux and accumulation within the epidermal and dermal layers, supporting the formulation’s potential to address both superficial infection and deeper wound pathology. An in vivo pilot study in a validated animal model of diabetic wound healing demonstrated accelerated re-epithelialization, enhanced granulation tissue formation, and reduced inflammatory markers relative to control groups. Histopathological analysis corroborated improved collagen deposition and neovascularization, consistent with clinically meaningful wound closure. Pharmacokinetic assessment revealed sustained local skin concentrations with minimal systemic exposure, reducing the risk of systemic adverse effects. Statistical analysis of outcomes employed a mixed-effects model to account for inter-subject variability, with significance set at p < 0.05. Sensitivity analyses confirmed robustness against minor formulation perturbations and environmental factors. The study also encompassed a preliminary human-factor evaluation to assess ease of application, comfort, and adherence potential among a cohort of volunteers with a history of DFUs. Collectively, the results indicate that the slow-release herbal extract-based topical formulation provides a synergistic, targeted, and patient-friendly approach to DFU management, offering antimicrobial protection, enhanced wound healing, and extended dosing intervals that may improve clinical outcomes and quality of life for patients with diabetes. Further large-scale clinical trials are recommended to confirm efficacy, safety, and long-term benefits in diverse patient populations.

Project Overview

What This Project Is About

---

A plain-language overview of the topic and what the project investigates.

---

---

The Problem It Addresses

---

What problem or gap this project tackles and why it matters to the field or society.

---

---

Objectives of the Project

---

1. Identify a safe, plant-based extract with potential healing effects for skin wounds. 2. Formulate a slow-release topical gel or cream using the chosen extract. 3. Test the release profile to ensure the active ingredient is delivered gradually. 4. Assess basic safety and skin compatibility through simple experiments. 5. Compare the new formulation to a standard treatment in a basic model.

---

---

What You Will Do Step by Step

---

1. Review simple literature on wound healing and herbal uses for ulcers. 2. Select 1–2 herbal extracts with reported benefits and prepare small batches. 3. Develop a carrier system that slows release of the extract on skin. 4. Do basic lab tests to check how fast the extract releases and how stable it is. 5. Conduct basic skin compatibility tests using simple models. 6. Analyze data to see if release is gradual and the product is safe. 7. Compare performance with a standard treatment in a preliminary way. 8. Write up findings and discuss practical implications.

---

---

Expected Outcome

A slow-release topical formulation that is safe for skin and shows potential for improved wound healing in a preliminary model, with data supporting gradual release and basic efficacy signals.